Literature DB >> 3120655

Comparative studies of serum and synovial fluid C reactive protein concentrations.

I F Rowe1, J Sheldon, P G Riches, A C Keat.   

Abstract

The relation between serum and synovial fluid (SF) C reactive protein (CRP) concentrations was investigated in a variety of arthritides, including rheumatoid arthritis (RA), psoriatic arthritis, reactive arthritis, and osteoarthritis. SF CRP levels were significantly reduced compared with serum levels in the inflammatory arthritides, but there was good correlation between serum and SF values. SF CRP values were all at the lower limit of the detectable range in osteoarthritis. In patients with RA or psoriatic arthritis followed up serially through an exacerbation of arthritis, changes in SF CRP reflected closely changes in serum CRP. In patients with RA SF/serum ratios of proteins of different molecular weight were used to derive a regression equation between SF/serum ratio and molecular mass. SF/serum values for CRP were significantly less than predicted from its molecular weight, suggesting that CRP is either being selectively bound in synovium or specifically consumed in SF and may be playing an important part in the inflammatory process in RA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120655      PMCID: PMC1003377          DOI: 10.1136/ard.46.10.721

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Serum and synovial fluid proteins in arthritis.

Authors:  M WILKINSON; B S JONES
Journal:  Ann Rheum Dis       Date:  1962-03       Impact factor: 19.103

2.  Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide.

Authors:  J E Volanakis; M H Kaplan
Journal:  Proc Soc Exp Biol Med       Date:  1971-02

3.  Familial occurrence of psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Ann Rheum Dis       Date:  1973-05       Impact factor: 19.103

4.  Interaction of C-reactive protein complexes with the complement system. I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin.

Authors:  M H Kaplan; J E Volanakis
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

5.  Localizing of C-reactive protein in synovium of patients with rheumatoid arthritis.

Authors:  J D Gitlin; J I Gitlin; D Gitlin
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec

Review 6.  Binding of C-reactive protein to C-carbohydrate and PC-substituted protein.

Authors:  E C Gotschlich; T Y Liu; E Oliveira
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  In vivo studies of serum C-reactive protein turnover in rabbits.

Authors:  M Chelladurai; S S Macintyre; I Kushner
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

8.  Correlation of clinical parameters of disease activity in rheumatoid arthritis with serum concentration of C-reactive protein and erythrocyte sedimentation rate.

Authors:  R K Mallya; F C de Beer; H Berry; E D Hamilton; B E Mace; M B Pepys
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

9.  Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.

Authors:  R K Mallya; D Vergani; D E Tee; L Bevis; F C de Beer; H Berry; E D Hamilton; B E Mace; M B Pepys
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

10.  Exacerbation of experimental poly-D-lysine arthritis by C-reactive protein.

Authors:  N C Phillips
Journal:  Agents Actions       Date:  1982-07
View more
  6 in total

1.  C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease.

Authors:  B Shine; J T Bourne; F Begum Baig; J Dacre; D V Doyle
Journal:  Ann Rheum Dis       Date:  1991-01       Impact factor: 19.103

2.  Pain sensitivity and pain reactivity in osteoarthritis.

Authors:  Yvonne C Lee; Bing Lu; Joan M Bathon; Jennifer A Haythornthwaite; Michael T Smith; Gayle G Page; Robert R Edwards
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10-18       Impact factor: 4.794

3.  Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.

Authors:  M T Walters; F K Stevenson; R Goswami; J L Smith; M I Cawley
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

Review 4.  A hypothesis resolving the apparently disparate activities of native and altered forms of human C-reactive protein.

Authors:  M J Shields
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 5.  C-reactive protein in human atherogenesis: facts and fiction.

Authors:  Oliver Zimmermann; Kefei Li; Myron Zaczkiewicz; Matthias Graf; Zhongmin Liu; Jan Torzewski
Journal:  Mediators Inflamm       Date:  2014-04-01       Impact factor: 4.711

6.  The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study.

Authors:  Yvonne C Lee; Lori B Chibnik; Bing Lu; Ajay D Wasan; Robert R Edwards; Anne H Fossel; Simon M Helfgott; Daniel H Solomon; Daniel J Clauw; Elizabeth W Karlson
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.